首页> 外文学位 >Molecular dynamics simulation of phase and structural transitions in model lung surfactant mixtures.
【24h】

Molecular dynamics simulation of phase and structural transitions in model lung surfactant mixtures.

机译:模型肺表面活性剂混合物中相和结构转变的分子动力学模拟。

获取原文
获取原文并翻译 | 示例

摘要

Lung surfactant (LS) is a complex mixture of lipids and proteins that reduces and regulates the surface tension in the lungs, thereby decreasing the work of breathing. A thorough understanding of LS function is critical to the development and optimization of synthetic surfactants for the treatment of neonatal and adult respiratory distress syndrome. We have utilized coarse-grained (CG) molecular dynamics simulation to study the dynamic, hysteretic changes occurring in the structure and phase of model surfactant mixtures with varying temperature, pressure and composition. In particular, we have studied the effects of the LS components palmitoyloleoylphosphatidylglycerol (POPG), palmitoyloleoylphosphatidylcholine (POPC), palmitic acid (PA), cholesterol, and two surface-active proteins SP-B 1--25 (the 25-residue N-terminal fragment of SP-B), and SP-C on model surfactant monolayers containing the primary lipid component dipalmitoylphosphatidylcholine (DPPC). The results indicate that POPG, POPC, SP-B1--25 and SP-C act as fluidizers and PA and cholesterol act as condensing agents, which change the phase-transition temperature, LC-LE phase distribution, and the extent of hysteresis. To explore the role of LS proteins SP-B and SP-C in storing and redelivering lipid from lipid monolayers during the compression and re-expansion occurring in lungs during breathing, we have simulated 2D-to-3D transitions at the interface. These simulations show that at near-zero surface tension the presence of a fluidizing agent, such as POPG, SP-C, or SP-B 1--25 decreases the monolayers resistance to bending allowing the monolayers to form large undulations and ultimately folds. Another folding mechanism is also observed in monolayers containing peptides, involving the lipid-mediated aggregation of the peptides into a defect, from which the fold can nucleate. The occurrence of folding depends on the hydrophobic character of the peptides if the number of hydrophobic residues is decreased significantly, monolayer folding does not occur. In contrast, the addition of PA has a charge-dependent condensing affect, which can eliminate folding. Our results suggest that the peptides play a significant role in the folding process, and provide a larger driving force for folding than does POPG. In addition to promoting fold formation, the peptides also display fusogenic behavior, which can lead to surface refining.
机译:肺表面活性剂(LS)是脂质和蛋白质的复杂混合物,可降低和调节肺部的表面张力,从而减少呼吸作用。对LS功能的透彻了解对于开发和优化用于治疗新生儿和成人呼吸窘迫综合征的合成表面活性剂至关重要。我们已经利用粗粒(CG)分子动力学模拟来研究在温度,压力和组成变化的情况下模型表面活性剂混合物的结构和相中发生的动态,滞后变化。特别是,我们研究了LS组分棕榈酰油酰磷脂酰甘油(POPG),棕榈酰油酰磷脂酰胆碱(POPC),棕榈酸(PA),胆固醇和两种表面活性蛋白SP-B 1--25(25个残基的N- SP-B的末端片段和SP-C在包含主要脂质成分二棕榈酰磷脂酰胆碱(DPPC)的模型表面活性剂单层上。结果表明,POPG,POPC,SP-B1--25和SP-C充当流化剂,PA和胆固醇充当凝结剂,它们改变了相变温度,LC-LE相分布和滞后程度。为了探索LS蛋白SP-B和SP-C在呼吸过程中发生在肺部的压缩和再膨胀过程中从脂质单层存储和重新输送脂质中的作用,我们在界面处模拟了2D到3D的转变。这些模拟表明,在接近零的表面张力下,流化剂(如POPG,SP-C或SP-B 1--25)的存在会降低单层的抗弯曲性,从而使单层形成较大的起伏并最终折叠。在含有肽的单层中还观察到另一种折叠机制,涉及脂质介导的肽聚集成缺陷,折叠可以从中形成核。如果疏水残基的数目显着减少,则折叠的发生取决于肽的疏水特性,不会发生单层折叠。相反,添加PA具有取决于电荷的缩合作用,可以消除折叠。我们的结果表明,该肽在折叠过程中起着重要作用,并且比POPG提供更大的折叠驱动力。除了促进折叠形成之外,这些肽还表现出融合行为,这可以导致表面细化。

著录项

  • 作者

    Duncan, Susan L.;

  • 作者单位

    University of Michigan.;

  • 授予单位 University of Michigan.;
  • 学科 Chemistry Molecular.Biophysics General.Physics Molecular.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 202 p.
  • 总页数 202
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:37:03

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号